BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12833565)

  • 1. An improved model of association for VH-VL immunoglobulin domains: asymmetries between VH and VL in the packing of some interface residues.
    Vargas-Madrazo E; Paz-García E
    J Mol Recognit; 2003; 16(3):113-20. PubMed ID: 12833565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
    Riechmann L
    J Mol Biol; 1996 Jun; 259(5):957-69. PubMed ID: 8683598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
    J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
    Tan PH; Sandmaier BM; Stayton PS
    Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The specificity properties that distinguish members of a set of homologous anti-digoxin antibodies are controlled by H chain mutations.
    Near RI; Bruccoleri R; Novotny J; Hudson NW; White A; Mudgett-Hunter M
    J Immunol; 1991 Jan; 146(2):627-33. PubMed ID: 1898959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
    Chen Y; Stollar BD
    J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on interaction kinetics of mutations at the VH-VL interface of Fabs depend on the structural context.
    Khalifa MB; Weidenhaupt M; Choulier L; Chatellier J; Rauffer-Bruyère N; Altschuh D; Vernet T
    J Mol Recognit; 2000; 13(3):127-39. PubMed ID: 10867708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallization of single-chain Fv proteins.
    Essig NZ; Wood JF; Howard AJ; Raag R; Whitlow M
    J Mol Biol; 1993 Dec; 234(3):897-901. PubMed ID: 8254684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
    Wörn A; Plückthun A
    Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis and prediction of VH/VL packing in antibodies.
    Abhinandan KR; Martin AC
    Protein Eng Des Sel; 2010 Sep; 23(9):689-97. PubMed ID: 20591902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
    Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM
    J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved aromatic residues as determinants in the folding and assembly of immunoglobulin variable domains.
    Campion SR
    Mol Immunol; 2016 Feb; 70():63-71. PubMed ID: 26742085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABangle: characterising the VH-VL orientation in antibodies.
    Dunbar J; Fuchs A; Shi J; Deane CM
    Protein Eng Des Sel; 2013 Oct; 26(10):611-20. PubMed ID: 23708320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V
    Fernández-Quintero ML; Hoerschinger VJ; Lamp LM; Bujotzek A; Georges G; Liedl KR
    Proteins; 2020 Jul; 88(7):830-839. PubMed ID: 31904133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncovalent association of heavy and light chains of human immunoglobulins. III. Specific interactions between VH and VL.
    Horne C; Klein M; Polidoulis I; Dorrington KJ
    J Immunol; 1982 Aug; 129(2):660-4. PubMed ID: 6806377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional mapping of conserved, surface-exposed charges of antibody variable domains.
    Weidenhaupt M; Khalifa MB; Hugo N; Choulier L; Altschuh D; Vernet T
    J Mol Recognit; 2002; 15(2):94-103. PubMed ID: 11954054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural invariants of antigen binding: comparison of immunoglobulin VL-VH and VL-VL domain dimers.
    Novotný J; Haber E
    Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4592-6. PubMed ID: 3927286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.